Actavis Pharma Co. v. Alcon Canada Inc. et al., (2015) 476 N.R. 309 (FCA)
Linked as:
Extract
Actavis Pharma Co. v. Alcon Canada Inc. et al., (2015) 476 N.R. 309 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
- Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
- Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
- Zero Spill Systems (Int'l) Inc. et al. v. 614248 Alberta Ltd. et al., (2015) 472 N.R. 127 (FCA)
